Related Experiment Video
Updated: Nov 24, 2025
09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
12.3K
Outcomes after Thrombectomy for Minor Stroke: A Meta-Analysis
Xiao Wu1, Mihir Khunte1, Sam Payabvash1
1Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut, USA.
World Neurosurgery
|December 28, 2020
Summary
Mechanical thrombectomy (MT) shows potential benefits for minor strokes with large-vessel occlusion, but results vary. Further randomized controlled trials are needed due to significant heterogeneity and selection bias in current studies.
Area of Science:
- Neurology
- Interventional Neuroradiology
- Stroke Medicine
Background:
- Minor stroke patients with large-vessel occlusion (LVO) represent a significant clinical challenge.
- Optimal treatment strategies, including mechanical thrombectomy (MT) versus medical management, require further elucidation.
Purpose of the Study:
- To compare the outcomes of mechanical thrombectomy (MT) against medical management in patients experiencing minor stroke symptoms due to large-vessel occlusion.
Main Methods:
- A comprehensive meta-analysis was conducted on 14 studies involving 2134 patients.
- Studies included MT as a standalone therapy or in combination with intravenous thrombolysis.
- Outcomes analyzed included excellent/good functional outcomes, mortality, and symptomatic intracranial hemorrhage (sICH).
Main Results:
- Immediate MT showed trends towards better excellent and good outcomes compared to best medical management, but with a higher incidence of sICH.
- MT compared to medical management (without thrombectomy) demonstrated similar excellent outcomes but increased mortality and sICH rates.
- Pooled data from all MT studies indicated 58.7% excellent outcomes, 76.2% good outcomes, 6.82% mortality, and 3.23% sICH.
Conclusions:
- Significant selection bias and heterogeneity exist across studies, impacting baseline characteristics and treatment protocols.
- Variations in patient selection, reperfusion rates, and MT criteria necessitate caution in interpreting current evidence.
- A high-quality randomized controlled trial is crucial to definitively establish the efficacy and safety of MT for minor strokes with LVO.
